CapForce Inc. (OPGN) Form 10-K — May 26, 2026
CapForce Inc. (formerly OpGen Inc.) reported $30.2 million in revenue for the year ended December 31, 2025, a 481% increase year-over-year, driven primarily by $30.2 million in listing sponsorship services. The company generated $23.6 million in net income, marking a sharp turnaround from its previous biotech operations which were deconsolidated following insolvency proceedings of its former subsidiaries, Curetis and Ares Genetics. The company has fully repositioned itself as a financial services and technology firm, focusing on capital markets advisory and a digital investment banking platform.
Key figures
- Revenue
- 30200000
- Net Income
- 23600000
- Total Debt
- 0
- Revenue Yoy
- 481%
- Cash Position
- 500000
- Shares Outstanding
- 12178278
- Operating expenses
- 6171922
- Gross proceeds 2024
- 5000000
- Gross proceeds 2025
- 500000
- Reverse split ratio
- 1:10
- Aei ownership percent
- 76.1
- Product sales revenue
- 0
- Laboratory services revenue
- 0
- Listing sponsorship revenue
- 30200000
Price after filing
Close on the filing date to close N calendar days later (from $1.50). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.